Recently, Guo et al. [138] showed anti-atherogenic effects in APOC3-KO golden Syrian hamster, suggesting that CRISPR-mediated knockout of APOC3 in human may be a potential therapeutic approach in alleviating atherosclerosis. Here, APOC3 is linked to atherosclerosis.